AAAAAA

   
Results: << | 101-125 | 126-126
Results: 101-125/126
LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2
Authors: LISSONI P BARNI S ANDRES M SCARDINO E VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: P. Lissoni et al., LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2, Tumori, 80(4), 1994, pp. 283-285
ONDANSETRON DOES NOT STIMULATE PROLACTIN-RELEASE IN BREAST-CANCER PATIENTS
Authors: LISSONI P CAZZANIGA M ROVELLI F MAININI E TANCINI G BARNI S
Citation: P. Lissoni et al., ONDANSETRON DOES NOT STIMULATE PROLACTIN-RELEASE IN BREAST-CANCER PATIENTS, Tumori, 80(3), 1994, pp. 209-211
SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I IN OPERABLE BREAST-CANCER IN RELATION TO THE MAIN PROGNOSTIC VARIABLES AND THEIR PERIOPERATIVECHANGES IN RELATION TO THOSE OF PROLACTIN
Authors: BARNI S LISSONI P BRIVIO F FUMAGALLI L MERLINI D CATALDO M ROVELLI F TANCINI G
Citation: S. Barni et al., SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I IN OPERABLE BREAST-CANCER IN RELATION TO THE MAIN PROGNOSTIC VARIABLES AND THEIR PERIOPERATIVECHANGES IN RELATION TO THOSE OF PROLACTIN, Tumori, 80(3), 1994, pp. 212-215
CORRELATION BETWEEN ULTRASTRUCTURAL AND HISTOCHEMICAL PARAMETERS IN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS REACTING WITH TARGET-CELLS IN-VITRO
Authors: NANO R BARNI S CAPELLI E CREMASCHI P CATANESE C TOMASELLI S NASCIMBENE C PROSPERI E
Citation: R. Nano et al., CORRELATION BETWEEN ULTRASTRUCTURAL AND HISTOCHEMICAL PARAMETERS IN LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS REACTING WITH TARGET-CELLS IN-VITRO, Acta oncologica, 33(2), 1994, pp. 165-169
EFFICACY OF THE CONCOMITANT ADMINISTRATION OF THE PINEAL HORMONE MELATONIN IN CANCER-IMMUNOTHERAPY WITH LOW-DOSE IL-2 IN PATIENTS WITH ADVANCED SOLID TUMORS WHO HAD PROGRESSED ON IL-2 ALONE
Authors: LISSONI P BARNI S CAZZANIGA M ARDIZZOIA A ROVELLI F BRIVIO F TANCINI G
Citation: P. Lissoni et al., EFFICACY OF THE CONCOMITANT ADMINISTRATION OF THE PINEAL HORMONE MELATONIN IN CANCER-IMMUNOTHERAPY WITH LOW-DOSE IL-2 IN PATIENTS WITH ADVANCED SOLID TUMORS WHO HAD PROGRESSED ON IL-2 ALONE, Oncology, 51(4), 1994, pp. 344-347
PROGNOSTIC FACTORS OF THE CLINICAL-RESPONSE TO SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 ALONE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: LISSONI P BARNI S ARDIZZOIA A CRISPINO S PAOLOROSSI F ANDRES M SCARDINO E TANCINI G
Citation: P. Lissoni et al., PROGNOSTIC FACTORS OF THE CLINICAL-RESPONSE TO SUBCUTANEOUS IMMUNOTHERAPY WITH INTERLEUKIN-2 ALONE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Oncology, 51(1), 1994, pp. 59-62
A RANDOMIZED STUDY WITH THE PINEAL HORMONE MELATONIN VERSUS SUPPORTIVE CARE ALONE IN PATIENTS WITH BRAIN METASTASES DUE TO SOLID NEOPLASMS
Authors: LISSONI P BARNI S ARDIZZOIA A TANCINI G CONTI A MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH THE PINEAL HORMONE MELATONIN VERSUS SUPPORTIVE CARE ALONE IN PATIENTS WITH BRAIN METASTASES DUE TO SOLID NEOPLASMS, Cancer, 73(3), 1994, pp. 699-701
A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA
Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A RICCI G ALDEGHI R BRIVIO F TISI E ROVELLI F RESCALDANI R QUADRO G MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA, British Journal of Cancer, 69(1), 1994, pp. 196-199
A SINGLE-STEP STAINING PROCEDURE FOR THE DETECTION AND SORTING OF UNFIXED APOPTOTIC THYMOCYTES
Authors: PELLICCIARI C MANFREDI AA BOTTONE MG SCHAACK V BARNI S
Citation: C. Pellicciari et al., A SINGLE-STEP STAINING PROCEDURE FOR THE DETECTION AND SORTING OF UNFIXED APOPTOTIC THYMOCYTES, European journal of histochemistry, 37(4), 1993, pp. 381-390
INVIVO BIOLOGICAL RESULTS OF THE ASSOCIATION BETWEEN INTERLEUKIN-2 AND INTERLEUKIN-3 IN THE IMMUNOTHERAPY OF CANCER
Authors: LISSONI P BARNI S TISI E ROVELLI F PITTALIS S RESCALDANI R VIGORE L BIONDI A ARDIZZOIA A TANCINI G
Citation: P. Lissoni et al., INVIVO BIOLOGICAL RESULTS OF THE ASSOCIATION BETWEEN INTERLEUKIN-2 AND INTERLEUKIN-3 IN THE IMMUNOTHERAPY OF CANCER, European journal of cancer, 29A(8), 1993, pp. 1127-1132
RESPIRATORY-DISTRESS SYNDROME IN PATIENTS WITH ADVANCED CANCER TREATED WITH PENTOXIFYLLINE - A RANDOMIZED STUDY
Authors: ARDIZZOIA A LISSONI P TANCINI G PAOLOROSSI F CRISPINO S VILLA S BARNI S
Citation: A. Ardizzoia et al., RESPIRATORY-DISTRESS SYNDROME IN PATIENTS WITH ADVANCED CANCER TREATED WITH PENTOXIFYLLINE - A RANDOMIZED STUDY, Supportive care in cancer, 1(6), 1993, pp. 331-333
CHANGES OF HEMATOPOIETIC ACTIVITY AND CHARACTERISTICS OF CIRCULATING BLOOD-CELLS IN TRITURUS-CARNIFEX AND TRITURUS-ALPESTRIS DURING THE WINTER PERIOD
Authors: BARNI S NANO R VIGNOLA C
Citation: S. Barni et al., CHANGES OF HEMATOPOIETIC ACTIVITY AND CHARACTERISTICS OF CIRCULATING BLOOD-CELLS IN TRITURUS-CARNIFEX AND TRITURUS-ALPESTRIS DURING THE WINTER PERIOD, Comparative haematology international, 3(3), 1993, pp. 159-163
CANCER-IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS ADMINISTRATION - POTENTIAL EFFICACY IN MOST SOLID TUMOR HISTOTYPES BY A CONCOMITANT TREATMENT WITH THE PINEAL HORMONE MELATONIN
Authors: LISSONI P BARNI S ARDIZZOIA A OLIVINI G BRIVIO F TISI E TANCINI G CHARACIEJUS D KOTHARI L
Citation: P. Lissoni et al., CANCER-IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS ADMINISTRATION - POTENTIAL EFFICACY IN MOST SOLID TUMOR HISTOTYPES BY A CONCOMITANT TREATMENT WITH THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 7(4), 1993, pp. 121-125
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS AND THEIR RELATION TO NEOPTERIN AND TUMOR-NECROSIS-FACTOR-ALPHA IN CANCER-PATIENTS
Authors: CRISPINO S LISSONI P ARDIZZOIA A ROVELLI F PEREGO MS GRASSI MG BARNI S PITTALIS S TANCINI G
Citation: S. Crispino et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVELS AND THEIR RELATION TO NEOPTERIN AND TUMOR-NECROSIS-FACTOR-ALPHA IN CANCER-PATIENTS, Journal of biological regulators and homeostatic agents, 7(3), 1993, pp. 92-94
INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA SECRETION BY PENTOXIFYLLINEIN ADVANCED CANCER-PATIENTS WITH ABNORMALLY HIGH BLOOD-LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA
Authors: LISSONI P ARDIZZOIA A PEREGO MS GRASSI MG AROSIO M DAMICO P CAZZANIGA M CRISPINO S TANCINI G BARNI S
Citation: P. Lissoni et al., INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA SECRETION BY PENTOXIFYLLINEIN ADVANCED CANCER-PATIENTS WITH ABNORMALLY HIGH BLOOD-LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA, Journal of biological regulators and homeostatic agents, 7(2), 1993, pp. 73-75
CYTOKINE REGULATION OF IRON-METABOLISM - EFFECT OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY ON FERRITIN, TRANSFERRIN AND IRON BLOOD-CONCENTRATIONS IN CANCER-PATIENTS
Authors: LISSONI P CAZZANIGA M ARDIZZOIA A ROSSINI F FIORELLI G TANCINI G PITTALIS S BARNI S
Citation: P. Lissoni et al., CYTOKINE REGULATION OF IRON-METABOLISM - EFFECT OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS THERAPY ON FERRITIN, TRANSFERRIN AND IRON BLOOD-CONCENTRATIONS IN CANCER-PATIENTS, Journal of biological regulators and homeostatic agents, 7(1), 1993, pp. 31-33
AMPLIFICATION OF EOSINOPHILIA BY MELATONIN DURING THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
Authors: LISSONI P ARDIZZOIA A TISI E ROSSINI F BARNI S TANCINI G CONTI A MAESTRONI GJM
Citation: P. Lissoni et al., AMPLIFICATION OF EOSINOPHILIA BY MELATONIN DURING THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 7(1), 1993, pp. 34-36
A RANDOMIZED STUDY OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY VERSUS INTERLEUKIN-2 PLUS INTERFERON-ALPHA AS FIRST LINE THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
Authors: LISSONI P BARNI S ARDIZZOIA A ANDRES M SCARDINO E CARDELLINI P DELLABITTA R TANCINI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY VERSUS INTERLEUKIN-2 PLUS INTERFERON-ALPHA AS FIRST LINE THERAPY FOR METASTATIC RENAL-CELL CARCINOMA, Tumori, 79(6), 1993, pp. 397-400
SUBCUTANEOUS THERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN METASTATIC GASTRIC-CANCER PATIENTS WITH LOW PERFORMANCESTATUS
Authors: LISSONI P BRIVIO F ARDIZZOIA A TANCINI G BARNI S
Citation: P. Lissoni et al., SUBCUTANEOUS THERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN METASTATIC GASTRIC-CANCER PATIENTS WITH LOW PERFORMANCESTATUS, Tumori, 79(6), 1993, pp. 401-404
IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS INTERFERON-BETA AS A 2ND-LINE THERAPY FOR METASTATIC COLORECTAL-CARCINOMA
Authors: BARNI S LISSONI P ARDIZZOLA A VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: S. Barni et al., IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS INTERFERON-BETA AS A 2ND-LINE THERAPY FOR METASTATIC COLORECTAL-CARCINOMA, Tumori, 79(5), 1993, pp. 343-346
IMMUNOENDOCRINE THERAPY WITH INTERLEUKIN-2 (IL-2) AND MEDROXYPROGESTERONE ACETATE (MPA) - A RANDOMIZED STUDY WITH OR WITHOUT MPA IN METASTATIC RENAL-CANCER PATIENTS DURING IL-2 MAINTENANCE TREATMENT AFTER RESPONSE OR STABLE DISEASE TO IL-2 SUBCUTANEOUS THERAPY
Authors: LISSONI P BARNI S TANCINI G BRIVIO F CARDELLINI P VAGHI M FOSSATI V FRIGERIO F
Citation: P. Lissoni et al., IMMUNOENDOCRINE THERAPY WITH INTERLEUKIN-2 (IL-2) AND MEDROXYPROGESTERONE ACETATE (MPA) - A RANDOMIZED STUDY WITH OR WITHOUT MPA IN METASTATIC RENAL-CANCER PATIENTS DURING IL-2 MAINTENANCE TREATMENT AFTER RESPONSE OR STABLE DISEASE TO IL-2 SUBCUTANEOUS THERAPY, Tumori, 79(4), 1993, pp. 246-249
RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY
Authors: LISSONI P MEREGALLI S FOSSATI V BARNI S TANCINI G BARIGOZZI P FRIGERIO F
Citation: P. Lissoni et al., RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY, Tumori, 79(3), 1993, pp. 198-201
PREVENTION BY L-CARNITINE OF INTERLEUKIN-2-RELATED CARDIAC TOXICITY DURING CANCER-IMMUNOTHERAPY
Authors: LISSONI P GALLI MA TANCINI G BARNI S
Citation: P. Lissoni et al., PREVENTION BY L-CARNITINE OF INTERLEUKIN-2-RELATED CARDIAC TOXICITY DURING CANCER-IMMUNOTHERAPY, Tumori, 79(3), 1993, pp. 202-204
A WEEKLY SCHEDULE OF EPIRUBICIN IN PRETREATED ADVANCED BREAST-CANCER
Authors: BARNI S ARCHILI C LISSONI P PAOLOROSSI F CRISPINO S TANCINI G
Citation: S. Barni et al., A WEEKLY SCHEDULE OF EPIRUBICIN IN PRETREATED ADVANCED BREAST-CANCER, Tumori, 79(1), 1993, pp. 45-48
A STUDY OF THE MECHANISMS INVOLVED IN THE IMMUNOSTIMULATORY ACTION OFTHE PINEAL HORMONE IN CANCER-PATIENTS
Authors: LISSONI P BARNI S TANCINI G ROVELLI F ARDIZZOIA A CONTI A MAESTRONI GJM
Citation: P. Lissoni et al., A STUDY OF THE MECHANISMS INVOLVED IN THE IMMUNOSTIMULATORY ACTION OFTHE PINEAL HORMONE IN CANCER-PATIENTS, Oncology, 50(6), 1993, pp. 399-402
Risultati: << | 101-125 | 126-126